"I was on 90 milligrams of oxycodone a day and still waking up at 3 a.m. in agony. I'd lost my job, my marriage was falling apart, and I couldn't play with my grandkids. Cannabis gave me my life back — not perfectly, but enough to matter."
— John M., 52, former construction foreman, Phoenix, Arizona
In 2017, John was supervising a concrete pour on a commercial construction site when a scaffolding failure sent him twelve feet to the ground. He landed on his lower back. The diagnosis — L4-L5 disc herniation with nerve root compression, plus fractures to two lumbar vertebrae — was severe enough that his surgeon told him he'd never return to physical work.
"The surgery went well, technically," John says. "But the pain never really went away. It changed — from sharp and stabbing to this deep, grinding ache that was always there. Some days it was a 4 out of 10. Other days I couldn't get out of bed."
His pain management physician prescribed a regimen that escalated over three years: first tramadol, then hydrocodone, eventually oxycodone. By 2020, John was taking 90mg of oxycodone daily — a dose that his doctor acknowledged was high but felt justified given the severity of his documented injury.
John is careful not to villainize his doctors. "They were trying to help me. Opioids work — at first. The problem is what happens after." What happened to John is well-documented in the medical literature: opioid-induced hyperalgesia, where long-term opioid use paradoxically increases pain sensitivity; tolerance, requiring ever-higher doses for the same effect; and physical dependence, where stopping the medication causes severe withdrawal.
"I was taking pills to function, but I wasn't really functioning. I was foggy all the time. I couldn't drive safely. I gained 40 pounds because I couldn't move. My wife — we've been married 28 years — she told me she felt like she was living with a ghost."
In 2021, John's pain management clinic began tapering his opioid dose as part of new prescribing guidelines. The taper was medically supervised and gradual, but it left him with inadequate pain control. "They cut me from 90mg to 60mg over three months. The pain came back hard. I was desperate."
Arizona legalized medical cannabis in 2010 and recreational use in 2020. John had dismissed it for years — "I grew up thinking marijuana was for teenagers who wanted to get high, not for a 50-year-old man with a broken back." It was his daughter, a registered nurse, who finally convinced him to speak with a cannabis-knowledgeable physician.
"She sent me research papers. Real studies, not just anecdotes. She showed me the data on opioid-sparing effects, on CBD for neuropathic pain. I was skeptical, but I was also out of options."
His consultation with a physician specializing in integrative pain management lasted ninety minutes. They reviewed his imaging, his medication history, his pain patterns. The physician recommended a structured approach: start with CBD-dominant products, assess response over four weeks, then consider adding low-dose THC if needed.
John's initial regimen was conservative: 25mg CBD twice daily via sublingual tincture, plus a topical CBD cream applied directly to his lower back three times a day. He kept a detailed pain diary — rating his pain on a 0–10 scale three times daily, tracking sleep quality, activity level, and medication use.
"The first two weeks, honestly, I didn't notice much. Maybe a slight edge taken off. But by week three, I was sleeping through the night for the first time in four years. That alone was transformative — sleep deprivation makes everything worse."
At his four-week follow-up, John's average pain score had dropped from 7.2 to 5.8. His physician added a low-dose THC component: 2.5mg THC combined with 25mg CBD in an evening capsule. "The THC made me nervous. I didn't want to be impaired. But at 2.5mg, I didn't feel high — I just felt... less pain. And I slept better."
Over six months, working closely with both his pain management physician and the cannabis specialist, John's oxycodone dose was reduced from 60mg to 20mg daily. His pain scores averaged 4.5 — not pain-free, but manageable.
Today, John takes 20mg oxycodone daily — down from 90mg — combined with 50mg CBD and 5mg THC in divided doses. He uses a topical CBD/THC cream for breakthrough pain. He's lost 25 of the 40 pounds he gained. He drives again. He attended his granddaughter's birthday party last month and got on the floor to play with her.
"I'm not cured. My back is still damaged. I still have bad days. But I have more good days than bad now, and that's a reversal from where I was."
His wife, Sandra, offered her perspective: "I have my husband back. He's present. He's engaged. He's not perfect — none of us are — but he's here."
John is emphatic on several points for anyone considering a similar path:
John's experience is consistent with emerging clinical evidence. A 2019 systematic review in JAMA Internal Medicine found that medical cannabis legalization was associated with a 14.4% reduction in opioid prescribing. A 2020 survey of chronic pain patients found that 53% reported substituting cannabis for opioids, with 80% reporting cannabis was more effective. The opioid-sparing potential of cannabis is one of the most actively researched areas in pain medicine. However, individual responses vary significantly, and opioid tapering must always be medically supervised.